Monthly Archives: August 2017

Innately Innovative: IFM Therapeutics Acquired By BMS
August 3, 2017

Today BMS announced the acquisition of IFM Therapeutics, an emerging biotech focused on modulating core innate immune pathways to treat cancer and autoimmune disease. As described in the press release, BMS will acquire the company for $300M upfront, with potentially

1 Comment